INmune Bio, Inc. Announces Pre-Clinical Data That Support a Pioneering Approach to Treating Duchenne Muscular Dystrophy

(marketscreener.com) Boca Raton, Florida, Jan. 25, 2023 -- INmune Bio, Inc.  , a clinical-stage immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, in collaboration with Professor Armando Villa…

Visit Student Forum